Skip to main content

. 1953 Apr;32(4):381–389. doi: 10.1172/JCI102749

IDENTIFICATION OF A THROMBOPLASTIN INHIBITOR IN SERUM AND IN PLASMA ^¹

Gerard F Lanchantin ^1,², Arnold G Ware ^1,²

PMCID: PMC438352 PMID: 13052697

381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ALEXANDER B., GOLDSTEIN R., LANDWEHR G. The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin. J Clin Invest. 1950 Jul;29(7):881–895. doi: 10.1172/JCI102322. [DOI] [PMC free article] [PubMed] [Google Scholar]
FIALA S. A thermolabile inhibitor of plasma coagulation. Nature. 1951 Feb 17;167(4242):279–279. doi: 10.1038/167279a0. [DOI] [PubMed] [Google Scholar]
FIALA S. On the role of a protein inhibitor in the first stage of blood coagulation. Arch Int Physiol. 1951 Feb;58(4):386–411. doi: 10.3109/13813455109144971. [DOI] [PubMed] [Google Scholar]
HONORATO R. Hemofilia y sindromas hemofiläcos; patogenia y tratamiento. Rev Med Chil. 1952 Jan;80(1):1–10. [PubMed] [Google Scholar]
JACOX R. F., BAYS R. F. The relationship of plasma prothrombin concentration and the degradation rate of serum "prothrombin-converting factor" during dicumarol therapy. Blood. 1950 Apr;5(4):313–319. [PubMed] [Google Scholar]
MANN F. D., HURN M. Co-thromboplastin, a probable factor in coagulation of blood. Am J Physiol. 1951 Jan;164(1):105–110. doi: 10.1152/ajplegacy.1950.164.1.105. [DOI] [PubMed] [Google Scholar]
TOCANTINS L. M., CARROLL R. T., HOLBURN R. H. The clot accelerating effect of dilution on blood and plasma. Relation to the mechanism of coagulation of normal and hemophilic blood. Blood. 1951 Aug;6(8):720–739. [PubMed] [Google Scholar]
WARE A. G., STRAGNELL R. An improved one-stage prothrombin method. Am J Clin Pathol. 1952 Aug;22(8):791–797. doi: 10.1093/ajcp/22.8_ts.791. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES